Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Emodin inhibits current through SARS-associated coronavirus 3a protein.

Identifieur interne : 002121 ( Main/Exploration ); précédent : 002120; suivant : 002122

Emodin inhibits current through SARS-associated coronavirus 3a protein.

Auteurs : Silvia Schwarz [République populaire de Chine] ; Kai Wang ; Wenjing Yu ; Bing Sun ; Wolfgang Schwarz

Source :

RBID : pubmed:21356245

Descripteurs français

English descriptors

Abstract

The open-reading-frame 3a of SARS coronavirus (SARS-CoV) had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release. Drugs that inhibit the ion channel formed by the 3a protein can be expected to inhibit virus release, and would be a source for the development of novel therapeutic agents. Here we demonstrate that emodin can inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43 with a K1/2 value of about 20 μM. We suggest that viral ion channels, in general, may be a good target for the development of antiviral agents.

DOI: 10.1016/j.antiviral.2011.02.008
PubMed: 21356245


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Emodin inhibits current through SARS-associated coronavirus 3a protein.</title>
<author>
<name sortKey="Schwarz, Silvia" sort="Schwarz, Silvia" uniqKey="Schwarz S" first="Silvia" last="Schwarz">Silvia Schwarz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Shanghai Research Center for Acupuncture & Meridians, 199 Guoshoujing Rd., Shanghai 201203, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Shanghai Research Center for Acupuncture & Meridians, 199 Guoshoujing Rd., Shanghai 201203</wicri:regionArea>
<wicri:noRegion>Shanghai 201203</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wang, Kai" sort="Wang, Kai" uniqKey="Wang K" first="Kai" last="Wang">Kai Wang</name>
</author>
<author>
<name sortKey="Yu, Wenjing" sort="Yu, Wenjing" uniqKey="Yu W" first="Wenjing" last="Yu">Wenjing Yu</name>
</author>
<author>
<name sortKey="Sun, Bing" sort="Sun, Bing" uniqKey="Sun B" first="Bing" last="Sun">Bing Sun</name>
</author>
<author>
<name sortKey="Schwarz, Wolfgang" sort="Schwarz, Wolfgang" uniqKey="Schwarz W" first="Wolfgang" last="Schwarz">Wolfgang Schwarz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21356245</idno>
<idno type="pmid">21356245</idno>
<idno type="doi">10.1016/j.antiviral.2011.02.008</idno>
<idno type="wicri:Area/PubMed/Corpus">001544</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001544</idno>
<idno type="wicri:Area/PubMed/Curation">001544</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001544</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001501</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001501</idno>
<idno type="wicri:Area/Ncbi/Merge">002300</idno>
<idno type="wicri:Area/Ncbi/Curation">002300</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002300</idno>
<idno type="wicri:Area/Main/Merge">002147</idno>
<idno type="wicri:Area/Main/Curation">002121</idno>
<idno type="wicri:Area/Main/Exploration">002121</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Emodin inhibits current through SARS-associated coronavirus 3a protein.</title>
<author>
<name sortKey="Schwarz, Silvia" sort="Schwarz, Silvia" uniqKey="Schwarz S" first="Silvia" last="Schwarz">Silvia Schwarz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Shanghai Research Center for Acupuncture & Meridians, 199 Guoshoujing Rd., Shanghai 201203, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Shanghai Research Center for Acupuncture & Meridians, 199 Guoshoujing Rd., Shanghai 201203</wicri:regionArea>
<wicri:noRegion>Shanghai 201203</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wang, Kai" sort="Wang, Kai" uniqKey="Wang K" first="Kai" last="Wang">Kai Wang</name>
</author>
<author>
<name sortKey="Yu, Wenjing" sort="Yu, Wenjing" uniqKey="Yu W" first="Wenjing" last="Yu">Wenjing Yu</name>
</author>
<author>
<name sortKey="Sun, Bing" sort="Sun, Bing" uniqKey="Sun B" first="Bing" last="Sun">Bing Sun</name>
</author>
<author>
<name sortKey="Schwarz, Wolfgang" sort="Schwarz, Wolfgang" uniqKey="Schwarz W" first="Wolfgang" last="Schwarz">Wolfgang Schwarz</name>
</author>
</analytic>
<series>
<title level="j">Antiviral research</title>
<idno type="eISSN">1872-9096</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Emodin (pharmacology)</term>
<term>Humans</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (physiology)</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
<term>Virus Release (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (pharmacologie)</term>
<term>Humains</term>
<term>Libération de particules virales ()</term>
<term>Lignée cellulaire</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (physiologie)</term>
<term>Émodine (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
<term>Emodin</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
<term>Virus Release</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antiviraux</term>
<term>Émodine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Libération de particules virales</term>
<term>Lignée cellulaire</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The open-reading-frame 3a of SARS coronavirus (SARS-CoV) had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release. Drugs that inhibit the ion channel formed by the 3a protein can be expected to inhibit virus release, and would be a source for the development of novel therapeutic agents. Here we demonstrate that emodin can inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43 with a K1/2 value of about 20 μM. We suggest that viral ion channels, in general, may be a good target for the development of antiviral agents.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Schwarz, Wolfgang" sort="Schwarz, Wolfgang" uniqKey="Schwarz W" first="Wolfgang" last="Schwarz">Wolfgang Schwarz</name>
<name sortKey="Sun, Bing" sort="Sun, Bing" uniqKey="Sun B" first="Bing" last="Sun">Bing Sun</name>
<name sortKey="Wang, Kai" sort="Wang, Kai" uniqKey="Wang K" first="Kai" last="Wang">Kai Wang</name>
<name sortKey="Yu, Wenjing" sort="Yu, Wenjing" uniqKey="Yu W" first="Wenjing" last="Yu">Wenjing Yu</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Schwarz, Silvia" sort="Schwarz, Silvia" uniqKey="Schwarz S" first="Silvia" last="Schwarz">Silvia Schwarz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002121 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002121 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21356245
   |texte=   Emodin inhibits current through SARS-associated coronavirus 3a protein.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21356245" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021